240 related articles for article (PubMed ID: 10769276)
1. Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus.
Evans M; Anderson RA; Graham J; Ellis GR; Morris K; Davies S; Jackson SK; Lewis MJ; Frenneaux MP; Rees A
Circulation; 2000 Apr; 101(15):1773-9. PubMed ID: 10769276
[TBL] [Abstract][Full Text] [Related]
2. Prolonged deterioration of endothelial dysfunction in response to postprandial lipaemia is attenuated by vitamin C in Type 2 diabetes.
Anderson RA; Evans LM; Ellis GR; Khan N; Morris K; Jackson SK; Rees A; Lewis MJ; Frenneaux MP
Diabet Med; 2006 Mar; 23(3):258-64. PubMed ID: 16492208
[TBL] [Abstract][Full Text] [Related]
3. Ciprofibrate effects on carbohydrate and lipid metabolism in type 2 diabetes mellitus subjects.
Hernández-Mijares A; Lluch I; Vizcarra E; Martínez-Triguero ML; Ascaso JF; Carmena R
Nutr Metab Cardiovasc Dis; 2000 Feb; 10(1):1-6. PubMed ID: 10812581
[TBL] [Abstract][Full Text] [Related]
4. Effect of ciprofibrate on lipoprotien metabolism and oxidative stress parameters in patients with type 2 diabetes mellitus and atherogenic lipoprotein phenotype.
Raslová K; Nagyová A; Dobiásová M; Ptácková K; Dusinská M
Acta Diabetol; 2000; 37(3):131-4. PubMed ID: 11277313
[TBL] [Abstract][Full Text] [Related]
5. [Effect of ciprofibrate on the endothelial dysfunction of patients with combined dyslipidemia].
Kovács I; Tarján J; Császár A
Orv Hetil; 2001 Apr; 142(15):775-9. PubMed ID: 11367862
[TBL] [Abstract][Full Text] [Related]
6. The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes.
Anderson RA; Evans ML; Ellis GR; Graham J; Morris K; Jackson SK; Lewis MJ; Rees A; Frenneaux MP
Atherosclerosis; 2001 Feb; 154(2):475-83. PubMed ID: 11166782
[TBL] [Abstract][Full Text] [Related]
7. Effects of insulin lispro and chronic vitamin C therapy on postprandial lipaemia, oxidative stress and endothelial function in patients with type 2 diabetes mellitus.
Evans M; Anderson RA; Smith JC; Khan N; Graham JM; Thomas AW; Morris K; Deely D; Frenneaux MP; Davies JS; Rees A
Eur J Clin Invest; 2003 Mar; 33(3):231-8. PubMed ID: 12641541
[TBL] [Abstract][Full Text] [Related]
8. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
[TBL] [Abstract][Full Text] [Related]
9. Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study.
Aguilar-Salinas CA; Fanghänel-Salmón G; Meza E; Montes J; Gulías-Herrero A; Sánchez L; Monterrubio-Flores EA; González-Valdez H; Gómez Pérez FJ
Metabolism; 2001 Jun; 50(6):729-33. PubMed ID: 11398153
[TBL] [Abstract][Full Text] [Related]
10. Ciprofibrate and lipid profile.
Chandler HA; Batchelor AJ
Lancet; 1994 Jul; 344(8915):128-9. PubMed ID: 7912363
[No Abstract] [Full Text] [Related]
11. Effects of simvastatin and ciprofibrate alone and in combination on lipid profile, plasma fibrinogen and low density lipoprotein particle structure and distribution in patients with familial combined hyperlipidaemia and coronary artery disease.
Kontopoulos AG; Athyros VG; Papageorgiou AA; Hatzikonstandinou HA; Mayroudi MC; Boudoulas H
Coron Artery Dis; 1996 Nov; 7(11):843-50. PubMed ID: 8993943
[TBL] [Abstract][Full Text] [Related]
12. Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymes.
Rizos E; Bairaktari E; Ganotakis E; Tsimihodimos V; Mikhailidis DP; Elisaf M
J Cardiovasc Pharmacol Ther; 2002 Oct; 7(4):219-26. PubMed ID: 12490967
[TBL] [Abstract][Full Text] [Related]
13. Effect of statin versus fibrate on postprandial endothelial dysfunction: role of remnant-like particles.
Wilmink HW; Twickler MB; Banga JD; Dallinga-Thie GM; Eeltink H; Erkelens DW; Rabelink TJ; Stroes ES
Cardiovasc Res; 2001 Jun; 50(3):577-82. PubMed ID: 11376633
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia.
Bruckert E; De Gennes JL; Malbecq W; Baigts F
Clin Cardiol; 1995 Nov; 18(11):621-9. PubMed ID: 8590530
[TBL] [Abstract][Full Text] [Related]
15. Rosiglitazone improves postprandial triglyceride and free fatty acid metabolism in type 2 diabetes.
van Wijk JP; de Koning EJ; Castro Cabezas M; Rabelink TJ
Diabetes Care; 2005 Apr; 28(4):844-9. PubMed ID: 15793183
[TBL] [Abstract][Full Text] [Related]
16. Pronounced postprandial lipemia impairs endothelium-dependent dilation of the brachial artery in men.
Gaenzer H; Sturm W; Neumayr G; Kirchmair R; Ebenbichler C; Ritsch A; Föger B; Weiss G; Patsch JR
Cardiovasc Res; 2001 Dec; 52(3):509-16. PubMed ID: 11738068
[TBL] [Abstract][Full Text] [Related]
17. Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.
Feinglos MN; Thacker CH; English J; Bethel MA; Lane JD
Diabetes Care; 1997 Oct; 20(10):1539-42. PubMed ID: 9314631
[TBL] [Abstract][Full Text] [Related]
18. Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial.
Sawada T; Tsubata H; Hashimoto N; Takabe M; Miyata T; Aoki K; Yamashita S; Oishi S; Osue T; Yokoi K; Tsukishiro Y; Onishi T; Shimane A; Taniguchi Y; Yasaka Y; Ohara T; Kawai H; Yokoyama M
Cardiovasc Diabetol; 2016 Aug; 15(1):121. PubMed ID: 27565734
[TBL] [Abstract][Full Text] [Related]
19. Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes.
Bozzetto L; Annuzzi G; Corte GD; Patti L; Cipriano P; Mangione A; Riccardi G; Rivellese AA
Atherosclerosis; 2011 Jul; 217(1):142-8. PubMed ID: 21481394
[TBL] [Abstract][Full Text] [Related]
20. Ezetimibe improves postprandial hyperlipemia and its induced endothelial dysfunction.
Yunoki K; Nakamura K; Miyoshi T; Enko K; Kohno K; Morita H; Kusano KF; Ito H
Atherosclerosis; 2011 Aug; 217(2):486-91. PubMed ID: 21592480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
